EntreMed, Boston Life Sciences, Vical Among 40-Plus

                     Public/Private Companies
Streamed Live March 28 by InformedInvestors.com at Boston BIO 2000 Conference 
BOSTON, March 27 /PRNewswire/ -- Nearly 50 companies, both publicly- and
privately-held, will be presenting on the second day of the huge International
Investors & Partnering Forum at the Biotechnology Industry Organization's
(BIO) annual conference and exhibition March 28 in Boston. 
Among the public companies scheduled to present Tuesday include local
companies Boston Life Sciences (Nasdaq: BLSI) and private company Genzyme Corp
plus its publicly-traded affiliates Genzyme Transgenics (Nasdaq: GZTC) and
Genzyme Molecular Oncology (Nasdaq: GZMO). Other high-profile presenting
companies are EntreMed (Nasdaq: ENMD) and Vical (Nasdaq: VICL). 
To tune in free and live beginning at 8 a.m. EST, and for the full
schedule, visit www.informedinvestors.com and click on "Listen to BIO 2000."
Executive presentations for the complete International Investors and
Partnering Forum component of the BIO conference will also be archived for
replay. In addition, audio tapes are available. 
"Live streaming of both public and private companies gives biotech
investors anywhere in the world true and deep insight into the direction and
drivers of the biotechnology industry," said Tim Quast, InformedInvestors.com
President and COO. "We are delighted to work with BIO to bring these
fascinating presentations to investors." 
EntreMed is among the most visible companies in biotechnology. The
Rockville, Md.-based company bills itself as "The Angiogenesis Company(TM)"
and is a leader in the field of antiangiogenesis research, which involves the
inhibition of abnormal blood vessel growth associated with a broad range of
diseases. EntreMed's science applied to cancer treatments has received
substantial publicity and generated wide investor interest. 
Other public companies scheduled Tuesday include ArQule (Nasdaq: ARQL),
Trega Biosciences (Nasdaq: TRGA) and Creative BioMolecules (Nasdaq: CBMI).
Nearly 40 private companies are also scheduled to present their business
prospects and scientific progress. Companies present in two simultaneous
The Biotechnology Industry Organization (BIO) represents biotechnology
companies, academic institutions, state biotechnology centers and related
organizations throughout the United States and in many other countries. The
members of BIO apply biological knowledge and techniques to develop products
and services for use in health care, agriculture, environmental remediation,
and other fields. See details at www.bio.org. 
InformedInvestors.com is the leading producer of online and offline
industry-specific investment conferences for individual investors and offers a
growing stable of resources for in-depth sector-analysis, including the weekly
biotech-sector radio show, "BioTalk."

SOURCE  InformedInvestors.com 
-0-                             03/27/2000 
/CONTACT:  Steve Chanecka of InformedInvestors.com, 916-780-6100, or

    /Web site:  http://www.bio.org/
    /Web site:  http://www.informedinvestors.com/

CO:  InformedInvestors.com; Boston Life Sciences; Genzyme Corp.; Genzyme
     Transgenics; Genzyme Molecular Oncology; EntreMed; Vical; ArQule; Trega

 Biosciences; Creative BioMolecules; Biotechnology Industry Organization
ST:  California, Massachusetts, Maryland
-0- Mar/27/2000   16:14
EOS   (PRN)    Mar/27/2000    16:14       85
-0- (PRN) Mar/27/2000   16:29
Press spacebar to pause and continue. Press esc to stop.